Pulmonary and psychosocial findings at enrollment in the ACCESS study

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 22, Issue 2, 2005, Pages 147-153

  Yeager, Henry ^a,l   Rossman, Milton D ^b   Baughman, Robert P ^c   Teirstein, Alvin S ^d   Judson, Marc A ^e   Rabin, David L ^a   Iannuzzi, Michael C ^f   Rose, Cecile ^g   Bresnitz, Eddy A ^b   DePalo, Louis ^d   Hunninghake, Gary ^h   Johns, Carol J ⁱ   McLennan, Geoffrey ^h   Moller, David R ⁱ   Newman, Lee S ^g   Rybicki, Benjamin ^f   Weinberger, Steven E ^j   Wilkins, Patricia C ^k   Cherniack, Rueben ^g  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^h UNIVERSITY OF IOWA   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^k Clinical Trials & Surveys Corp   (United States)

^l GEORGETOWN UNIVERSITY HOSPITAL   (United States)

more..

Author keywords

Health related quality of life; Pulmonary disease; Sarcoidosis

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHILD; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFANT; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RACE DIFFERENCE; SARCOIDOSIS; SOCIAL PSYCHOLOGY; SPIROMETRY; THORAX RADIOGRAPHY;

ADULT; AFRICAN AMERICANS; BIOPSY; CASE-CONTROL STUDIES; DEPRESSION; DYSPNEA; FEMALE; HUMANS; INCIDENCE; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PSYCHOLOGICAL TESTS; QUALITY OF LIFE; QUESTIONNAIRES; RADIOGRAPHY, THORACIC; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX; SPIROMETRY; UNITED STATES;

EID: 22544465274     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. ATS, ERS. WASOG: Statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160: 736-55.
2. Wirnsberger RM, de Vries J, Breteler MH, van Hech GL, Wouters EF, Drent M: Evaluation of quality of life in sarcoidosis patients. Respir Med 1998; 92: 750-6.
3. Drent M, Wirnsberger RM, Breteler MH, Koek LM, Wouters EF: Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15: 59-66.
4. De Vries J, Drent M, Van Heck GL, Wouters EF: Quality of life in sarcoidosis: a comparison between members of a patient organization and a random sample. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15: 183-8.
5. Hoistma E, De Vries J, Van Santen-Hoeufft M, Faber CG, Drent M: Impact of pain in a Dutch sarcoidosis population. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 33-9.
6. De Vries J, Drent M: Relationship between perceived stress and sarcoidosis in a Dutch patient population. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 57-63.
7. De Vries J, Rothkrantz-Kos S, Van Dieijen-Visser MP, Drent M: The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 127-36.
8. Verbraecken J, Hoitsma E, Van Der Grinten CPM, Cobben NAM, Wouters EFM, Drent M: Sleep disturbances associated with periodic leg movements in chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 137-46.
9. Chang JA, Curtis JR, Patrick DL, Raghu G: Assessment of health-related quality of life in patients with interstitial lung disease. Chest 1999; 116: 1175-82.
10. Chang H, Steimel J, Moller DR, et al: Depression in sarcoidosis. Am J Respir Crit Care Med 2001; 163: 329-34.
11. ACCESS Research Group: Design of a case control etiologic study of sarcoidosis. J Clin Epidemiology 1999; 52: 1173-86.
12. Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H Jr., ACCESS Research group: Defining organ involvement in sarcoidosis: The ACCESS proposed instrument. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 75-86.
13. Baughman RP, Teirstein AS, Judson MA, et al: Clinical characteristics of patients in a case control study of sarcoidosis. Am J Resp Crit Care Med 2002; 164: 1885-9.
14. Walters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM: A clinical radiographic and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Resp Dis 1986; 133: 97-103.
15. Scadding JG: Prognosis of intrathoracic sarcoidosis in England: A review of 136 cases after five years observation. Br Med Journal 1962; 2: 1165-72.
16. American Thoracic Society: Lung function testing: selection of reference values and interpretative strategies. Am Rev Resp Dis 1991; 144: 1202-18.
17. American Thoracic Society: Standardization of spirometry: 1994 update. Am J Resp Crit Care Med 1995; 152: 1107-36.
18. Hankinson JL, Odenkrantz JR, Fedan KB: Spirometric reference values from a sample of the general U.S. population. Am J Resp Crit Care Med 1999; 159: 179-87.
19. Pauwels RA, Buist AS, Calverley PMA, et al: Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001; 163: 1256-76.
20. Medical Research Council. Committee on research in chronic bronchitis: Instructions for use of the questionnaire on respiratory symptoms. Devon, UK: W.J. Holman, 1966.
21. Radloff LS: The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
22. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). Medic Care 1992; 30: 473-83.
23. nd ed. New York. New York: Wiley and Sons 1981; 19-32, 56-82, 165-73.
24. Hosmer DW, Lemeshow S: Applied Logistic Regression. New York, New York: John Wiley and Sons 1989; 25-37, 106-18.
25. th ed. Ames. Iowa: Iowa State University Press 1967; 91-116, 317-21.
26. Young RC Jr, Carr C, Shelton TG, et al: Sarcoidosis: relationship between changes in lung structure and function. Am Rev Resp Dis 1967; 95: 224-38.
27. Miller A, Chuang M, Teirstein AS, Siltzbach LE: Pulmonary function in stages 1 and II pulmonary sarcoidosis. Ann NY Acad Sci 1976; 278: 292-300.
28. Muller NL, Mawson JB, Mathieson JR, Abboud R, Ostrow DN, Champion P: Sarcoidosis: correlation of extent of disease at CT with clinical, functional, and radiographic findings. Radiology 1989; 171: 613-18.
29. Lodenkemper R, Kloppenborg A, Schoenfeld N, Grosser H, Costabel U, WATL Study Group: Clinical findings in 715 patients with newly detected pulmonary sarcoidosis - Results of a cooperative study in former West Germany and Switzerland. Sarcoidosis Vasc Diffuse Lung Dis 1998; 17: 178-82.
30. th International Conference on Sarcoidosis and Other Granulomatous Diseases. Cardiff, Wales, UK: Alpha Omega Publishing Ltd 1980: 331-6.
31. Young RL, Krumholtz RA, Harkleroad LE: A physiologic roentgenographic disparity in sarcoid patients. Dis Chest 1966; 50: 81-6.
32. Carrington CB, Gaensler EA, Mikus JP, et al: Structure and function in sarcoidosis. Ann NY Acad Sci 1976; 278: 265-83.
33. McLoud TC, Epler GR, Gaensler EA, Burke GW, Carrington CB: A radiographic-classification for sarcoidosis: physiologic correlation. Invest Radiology 1982; 17: 129-38.
34. Medinger AE, Khouri S, Rohatgi PK: Sarcoidosis: the value of exercise testing. Chest 2001; 120: 93-101.
35. Baydur A, Alsalek A, Louie SG, Sharma OP: Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis. Chest 2001; 120: 102-8.
36. Douglas JG, Middleton WG, Gaddie J, et al: Sarcoidosis: a disorder commoner in non-smokers? Thorax 1986: 465: 625-31.
37. Valeyre D, Soler P, Clerici C, et al: Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 1998; 43: 516-24.
38. Newman LS, Rose CS, Bresnitz E, et al: A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Resp Crit Care Med 2004; 170: 1324-30.
39. Strom KE, Eklund AG: Smoking does not prevent the onset of respiratory failure in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1993; 10: 26-8.
40. Baydur AI, Sharma OP: Pulmonary function. In: James DG (ed): Sarcoidosis. Lung Biology in Health and Disease. Volume 73. New York. New York: Marcel Dekker Inc. 1994: 261-6.
41. Paramothayan S, Jones PW: Corticosteroid therapy in pulmonary sarcoidosis: a systematic review. JAMA 2002; 287: 1301-7.
42. Manning HL, Schwartzstein RM: Mechanisms of dyspnea. In: Mahler DA (ed): Dyspnea. Lung Biology in Health and Disease. Volume III. New York, New York: Marcel Dekker Inc. 1998: 63-95.
43. Harver A, Mahler DA: Dyspnea sensation, symptom, and illness. In: Mahler DA (ed): Dyspnea. Lung Biology in Health and Disease. Volume III. New York, New York: Marcel Dekker Inc. 1998: 1-34.
44. Sharma OP: Sarcoidosis in the aged. Geriatrics 1973; 28: 76-85.
45. Margolis ML, Israel HL: Sarcoidosis in older patients clinical characteristics and course. Geriatrics 1983; 38: 121-4.
46. Lenner R, Schilero GJ, Padilla ML, Teirstein AS: Sarcoidosis presenting in patients older than 50 years. Sarcoidosis Vasc Diffusse Lung Dis 2002; 19: 143-7.
47. Mayock RL, Bertrand P, Morrison CE, Scott JH: Manifestations of sarcoidosis: analysis of 145 patients, with a review of nine series selected from the literature. Am J Med 1963; 35: 67-89.
48. Siltzbach LE, James DG, Neville E, et al: Course and prognosis of sarcoidosis around the world. Am J Med 1974; 57: 847-52.
49. Israel HL, Karlin P, Menduke H, Delisser OG: Factors affecting outcome of sarcoidosis. Influence of race, extrathoracic involvement, and initial radiologic lung lesions. Ann NY Acad Sci 1986; 465: 609-18.
50. th International Conference on Sarcoidosis. Cardiff, Wales, UK: Alpha Omega Publishing Ltd 1980; 508-13.
51. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC: Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidem 1997; 145: 234-41.
52. Cox CE, Donohue JF, Brown CD, Kataria YP, Judson MA: Health-related quality of life of persons with sarcoidosis. Chest 2004; 125: 997-1004.
53. Rizzato G, Palmieri G, Agrati AM, Zanussi C: The organ-specific extrapulmonary presentation of sarcoidosis: a frequent occurrence but a challenge to an early diagnosis. A 3-year-long prospective observational study. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 119-26.
54. Judson MA, Thompson BW, Rabin DL, et al: The diagnostic pathway to sarcoidosis. Chest 2003; 123: 406-12.
55. Drent M: Sarcoidosis: benefits of a multidisciplinary approach. Eur J Int Med 2003; 14: 217-20.